Tag: mannkind

October 21, 2018

5 Top Weekly NASDAQ Biotech Stocks: MannKind Leads the Pack

MannKind, Sierra Oncology, Eiger BioPharmaceuticals, Aevi Genomic Medicine and KalVista Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology...
October 16, 2018

United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement

United Therapeutics (Nasdaq: UTHR) and MannKind (Nasdaq: MNKD) announced the closing of their pending worldwide exclusive license and collaboration agreement...
September 9, 2018

5 Top Weekly NASDAQ Biotech Stocks: MannKind Soars 83 Percent

MannKind, Evofem Biosciences, Arbutus Biopharma, Infinity Pharmaceuticals and VBI Vaccines were last week's top gainers on the NASDAQ Biotechnology Index.
June 7, 2018

MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere

MannKind (Nasdaq:MNKD) announced that it has completed a Phase 1 clinical study of Treprostinil Technosphere (TreT) under an Investigational New...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018

FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

MannKind (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and...
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.